Novavax to Participate in Upcoming September Conferences

Rhea-AI Summary

Novavax (Nasdaq: NVAX), a global protein-based vaccine company, has announced its participation in two upcoming investor conferences in September 2024. The company will be present at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, featuring a fireside chat and investor meetings. Additionally, Novavax will attend the Baird 2024 Global Healthcare Conference on September 10, delivering a presentation and holding investor meetings.

Key participants from Novavax include Jim Kelly, Executive Vice President, CFO and Treasurer, and Dr. Robert Walker, Senior Vice President, CMO and Interim Head of R&D. Both events will take place in New York City. Replays of the fireside chat and presentation will be available on the company's website for 30 days following the conferences.

GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in two upcoming investor conferences.

H.C. Wainwright 26th Annual Global Investment Conference:
Fireside Chat
Date:		Monday, September 9, 2024
Time:		3:30 – 4:00 p.m. Eastern Time (ET)
Location:		New York City, New York
Moderator:		Vernon Bernardino, Managing Director, Senior Healthcare Analyst
Novavax participants:		Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer and Robert Walker, MD, Senior Vice President, Chief Medical Officer and Interim Head, Research and Development
Conference
Event:		Investor Meetings
Date:		Monday, September 9, 2024
Baird 2024 Global Healthcare Conference:
Presentation
Date:		Tuesday, September 10, 2024
Time:		3:10 – 3:40 p.m. ET
Location:		New York City, New York
Novavax participants:		Jim Kelly, Executive Vice President, Chief Financial Officer and Treasurer and Robert Walker, MD, Senior Vice President, Chief Medical Officer and Interim Head, Research and Development
Conference
Event:		Investor Meetings
Date:		Tuesday, September 10, 2024

A replay of the recorded fireside session and presentation will be available through the Events and Presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influence vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-september-conferences-302237833.html

SOURCE Novavax, Inc.

FAQ

When is Novavax (NVAX) participating in the H.C. Wainwright Global Investment Conference?

Novavax (NVAX) is participating in the H.C. Wainwright 26th Annual Global Investment Conference on Monday, September 9, 2024, in New York City.

What events will Novavax (NVAX) be involved in at the Baird 2024 Global Healthcare Conference?

At the Baird 2024 Global Healthcare Conference on Tuesday, September 10, 2024, Novavax (NVAX) will give a presentation from 3:10 - 3:40 p.m. ET and participate in investor meetings.

Who will represent Novavax (NVAX) at these September 2024 conferences?

Novavax (NVAX) will be represented by Jim Kelly, Executive Vice President, CFO and Treasurer, and Dr. Robert Walker, Senior Vice President, CMO and Interim Head of R&D.

How long will the replays of Novavax's (NVAX) conference sessions be available?

Replays of Novavax's (NVAX) recorded fireside chat and presentation will be available on the company's website for 30 days after each conference.